RxDoctor Payments Data

Mitchell Heun, MD

Family Medicine · Mankato, MNNPI 1750369765

Payments from drug & device makers

$627in general payments, 2019–2025

Across 40 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kowa Pharmaceuticals America, Inc.$62
  • AbbVie$60
  • Pfizer$38
  • Ironwood Pharmaceuticals, Inc$35
  • GSK$32
  • Biogen$31
  • plus $369 from 20 others

What the payments were for

  • Food & beverage$59595%
  • Education$325%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$627 in reported general payments places this provider in the 90th percentile of 1,162 family medicine providers in Minnesota.

See all family medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$118,694
Medicare patients
288
Services billed
13,863

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide43$54,786
XareltoRivaroxaban45$41,444
EliquisApixaban40$41,143
JardianceEmpagliflozin26$37,991
LinzessLinaclotide42$31,267
JanumetSitagliptin Phos/Metformin Hcl20$30,258
JanuviaSitagliptin Phosphate25$25,734
Bydureon BciseExenatide Microspheres17$25,311
TrulicityDulaglutide17$24,650
FarxigaDapagliflozin Propanediol16$19,755
DuleraMometasone/Formoterol22$9,902
Advair HfaFluticasone Propion/Salmeterol16$5,830
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$4,539
Incruse ElliptaUmeclidinium Bromide12$4,411
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate17$4,171

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$13$41,44445 claims
PfizerEliquis$38$41,14340 claims
Boehringer IngelheimJardiance$24$37,99126 claims
AbbVieLinzess$60$31,26742 claims
AstraZenecaFarxiga$24$19,75516 claims
GSKIncruse Ellipta$32$4,41112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,162 family medicine providers in Minnesota.

Other family medicine in Mankato

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →